The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen; Amgen; Amgen; Amgen
Stock and Other Ownership Interests - Amgen; Amgen; Amgen; Amgen
Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab.
 
Christine Megerdichian Parseghian
No Relationships to Disclose
 
Karl Beutner
No Relationships to Disclose
 
Michael Boedigheimer
Stock and Other Ownership Interests - Amgen; Amgen; Amgen; Amgen
 
Paul Ruff
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Dr. Reddy's Laboratories; Dr. Reddy's Laboratories; Dr. Reddy's Laboratories; Dr. Reddy's Laboratories; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
 
Timothy Jay Price
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen
 
Tae Won Kim
Employment - Asan Medical Center; Asan Medical Center; Asan Medical Center; Asan Medical Center
Research Funding - Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
 
Marwan Fakih
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
 
Agnes Ang
Employment - Amgen; Amgen; Amgen; Amgen
Stock and Other Ownership Interests - Amgen; Amgen; Amgen; Amgen